Jee Hun Lee

20PUBLICATIONS
120CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Jeremy S Abramson, David J Straus, Nancy L Bartlett

|Jun 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma.

Neha Akkad, Lei Feng, Jason R Westin

|May 01, 2025
Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results.

Bruce D Cheson, Nancy L Bartlett, Betsy Knopf

|Dec 02, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma.

Hun Ju Lee, Rod Ramchandren, Judah Friedman

|Aug 21, 2023
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.

Raphael E Steiner, Steven R Hwang, Arushi Khurana

Pageof 4

Frequent Collaborators

5 joint publications

Michael Wang

5 joint publications

Christopher R Flowers

5 joint publications

Sairah Ahmed

5 joint publications

Francisco Vega